Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation

Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation

Introduction: Patients with erectile dysfunction induced by diabetes mellitus (DMED) show a poor effect rate for oral phosphodiesterase type 5 inhibitors (PDE5is). Therefore, the new therapeutic strategy is necessary in patients with DMED. Aim: To investigate whether Tetrathiomolybdate (TM) suppleme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yinghao Yin, MS, Jingxuan Peng, MS, Jun Zhou, MS, Hanfei Chen, MS, Dongyi Peng, PhD, Dongjie Li, PhD, Yu Gan, PhD, Guangming Yin, PhD, Yuxin Tang, PhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Tetrathiomolybdate
Diabetes Mellitus
Erectile Dysfunction
Ceruloplasmin
eNOS
Medicine
R
Other systems of medicine
RZ201-999
Acceso en línea:https://doaj.org/article/288fc032c5c945c9aee31c19a0d4e9af
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/288fc032c5c945c9aee31c19a0d4e9af

Ejemplares similares